Hims & Hers Health (HIMS) Other financing activities (2019 - 2025)

Hims & Hers Health's (HIMS) quarterly Other financing activities came in at $34000.0 in Q4 2025, down 90.26% quarter-over-quarter from $349000.0 in Q3 2025.

Hims & Hers Health (HIMS) Other financing activities (2019 - 2025) Analysis & Trends

Hims & Hers Health has disclosed Other financing activities across 4 years of filings, most recently posting $34000.0 for Q4 2025.

  • Other financing activities for Q4 2025 came in at $34000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 77.25% YoY), and the FY2025 annual result was $3.4 million, changed N/A from the prior year.
  • Other financing activities came in at $34000.0 for Q4 2025 at Hims & Hers Health, down from $349000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $12.8 million in Q1 2021 to a low of $34000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 34,000.00
Dec 31, 2025 34,000.00
Sep 30, 2025 349,000.00
Sep 30, 2025 349,000.00
Jun 30, 2025 1.81 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 1.24 Mn
Mar 31, 2025 1.24 Mn
Jun 30, 2021 57,000.00
Jun 30, 2021 57,000.00
Mar 31, 2021 12.79 Mn
Mar 31, 2021 12.79 Mn
Dec 31, 2020 1.28 Mn
Dec 31, 2020 1.28 Mn
Sep 30, 2020 2.07 Mn
Sep 30, 2020 2.07 Mn
Jun 30, 2020 -100,000.00
Jun 30, 2020 -100,000.00
Mar 31, 2020 100,000.00
Mar 31, 2020 100,000.00